Back Samols, E, Marri, G, Marks, V (1966) 'Inter-relationship of glucagon, insulin and glucose: the insulinogenic effect of glucagon', Diabetes , 15, 855-66
The weight-lowering effects of GLP-1 RAs are mediated through multiple, interrelated mechanisms
Subcutaneous injections resolved the oral bioavailability issues of incretins while the short half-life barrier was resolved when researchers identified other animals that also produce similar GLP-1 molecules [25]
While trials suggest the weight loss achieved while taking semaglutide can be maintained while still taking the drugs, we also know that some people start to regain some weight, even before they stop
What are the potential side effects of GLP-1s